Intravitreal bevacizumab for idiopathic choroidal neovascularization

Journal of AAPOS

Volumn 13, Issue 3, 2009, Pages 296-298

  Çakir, Mehmet ^a   Çekiç, Osman ^a   Yilmaz, Ö Faruk ^a  

^a Beyoglu Eye Research and Training Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ABSENCE OF SIDE EFFECTS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; SCHOOL CHILD; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHILD; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; INJECTIONS; VISUAL ACUITY; VITREOUS BODY;

EID: 67349139221     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaapos.2008.12.003     Document Type: Article

References (10)

1. Sivaprasad S., and Moore A.T. Choroidal neovascularisation in children. Br J Ophthalmol 92 (2008) 451-454
2. Wilson M.E., and Mazur D.O. Choroidal neovascularization in children: Report of five cases and literature review. J Pediatr Ophthalmol Strabismus 25 (1988) 23-29
3. Rhee D.Y., Reichel E., Rogers A., and Strominger M. Subfoveal choroidal neovascularization in a 3-year-old child with North Carolina macular dystrophy. J AAPOS 11 (2007) 614-615
4. Derosa J.T., Yanuzzi L.A., Marmor L., et al. Risk factors for choroidal neovascularizationin young patients: A case-control study. Doc Ophthalmol 91 (1995-96) 207-222
5. Çaki{dotless}r M., Çekiç O., and Yi{dotless}lmaz OF. Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease. J AAPOS 13 (2009) 94-96
6. Uemura A., and Thomas M.A. Visual outcome after surgical removal of choroidal neovascularization in pediatric patients. Arch Ophthalmol 118 (2000) 1373-1378
7. Giansanti F., Virgilli G., Varano M., Tedeschi M., Rapizzi E., Giacomelli G., and Menchini U. Photodynamic therapy for choroidal neovascularization in pediatric patients. Retina 25 (2005) 590-596
8. Bashshur Z.F., Haddad Z.A., Schakal A., Jaafar R.F., Saab M., and Noureddin B.N. Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: A one-year prospective study. Am J Ophthalmol 145 (2008) 249-256
9. Nguyen Q.D., Shah S.M., Hafiz G., et al. Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration. Am J Ophthalmol 145 (2008) 257-266
10. Çaki{dotless}r M., Çekiç O., and Yi{dotless}lmaz OF. Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease. J AAPOS 12 (2008) 309-311